Is There a Pathway for Phosphatidylinositol 3-kinase Delta Inhibitors to Be Approved Therapeutics for B-cell Lymphoma Therapy
Overview
Overview
Journal
Expert Opin Pharmacother
Publisher
Informa Healthcare
Specialty
Pharmacology
Date
2023 Jun 9
PMID
37294016
Authors
Affiliations
Affiliations
Soon will be listed here.